Use access key #2 to skip to page content.
$18.94 -0.06 (-0.32%)
10/6/2008 4:03 PM

Pfizer, Inc. (PFE)

CAPS Rating:
****

A research-based, pharmaceutical Company which discovers, develops, manufactures and markets prescription medicines for humans and animals.

View All Commentary (PFE)

Recs

0

Avatar jc09058 (52.82) Submitted: 5/07/08 9:51 AM : Underperform Start Price: $19.83 PFE Score: -21.66

While this is a great stock as far as dividend payments go, I do not see anything in the immediate future to boost it's stock price. Nothing has been released, news wise, that would indicate the finish on testing or development of a new 'wonder' drug from Pfizer. Yet, with all of the money available to them, I am left wondering what they are planning for the future.

I bought this stock very cheap years ago and have been satisfied with the past results. As to whether I would purchase more now that it is cheaper, I am not sure yet. For now, I will hold on to it as long as dividends don't start to drop.

Report this Post Replies: 0 | Reply

Featured Broker Partners